Abstract Details
Martin A. Kohli
(University of Miami)
PRESENTER |
No disclosure on file |
No disclosure on file | |
Adam Naj, PhD | No disclosure on file |
No disclosure on file | |
James M. Meyer, PharmD (Marathon Pharmaceuticals, LLC) | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Patrice Whitehead | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
Gary W. Beecham, PhD (University of Miami, Hussman Institute for Human Genomics) | The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH. |
Jonathan Haines, MD (Vanderbilt University) | No disclosure on file |
Gerard Schellenberg, PhD | No disclosure on file |
Stephan Zuchner, MD, FAAN (University of Miami School of Medicine) | Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
Margaret A. Pericak-Vance, PhD (University of Miami Miller School of Medicine) | Dr. Pericak-Vance has nothing to disclose. |